LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 368

Search options

  1. Article ; Online: Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization.

    Cicone, Francesco / Gnesin, Silvano / Cremonesi, Marta

    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

    2021  Volume 65, Issue 4, Page(s) 327–332

    Abstract: Nuclear medicine therapeutic procedures have considerably expanded over the last few years, and their number is expected to grow exponentially in the future. Internal dosimetry has significantly developed as well, but has not yet been uniformly accepted ... ...

    Abstract Nuclear medicine therapeutic procedures have considerably expanded over the last few years, and their number is expected to grow exponentially in the future. Internal dosimetry has significantly developed as well, but has not yet been uniformly accepted as a valuable tool for prediction of therapeutic efficacy and toxicity. In this paper, we briefly summarize some of the arguments about the implementation of internal dosimetry in clinical practice. In addition, we provide a few examples of radionuclide anticancer therapies for which internal dosimetry demonstrated a significant impact on treatment optimization and patient outcome.
    MeSH term(s) Humans ; Nuclear Medicine ; Radiometry ; Radionuclide Imaging
    Language English
    Publishing date 2021-12-09
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 1281687-5
    ISSN 1827-1936 ; 0392-0208 ; 1125-0135 ; 1824-4661 ; 1824-4785
    ISSN (online) 1827-1936
    ISSN 0392-0208 ; 1125-0135 ; 1824-4661 ; 1824-4785
    DOI 10.23736/S1824-4785.21.03418-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Thermophysical and mechanical properties of biological tissues as a function of temperature: a systematic literature review.

    Bianchi, Leonardo / Cavarzan, Fabiana / Ciampitti, Lucia / Cremonesi, Matteo / Grilli, Francesca / Saccomandi, Paola

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

    2022  Volume 39, Issue 1, Page(s) 297–340

    Abstract: Background: Detailed information on the temperature dependence of tissue thermophysical and mechanical properties is pivotal for the optimal implementation of mathematical models and simulation-based tools for the pre-planning of thermal ablation ... ...

    Abstract Background: Detailed information on the temperature dependence of tissue thermophysical and mechanical properties is pivotal for the optimal implementation of mathematical models and simulation-based tools for the pre-planning of thermal ablation therapies. These models require in-depth knowledge of the temperature sensitivity of these properties and other influential terms (e.g., blood perfusion and metabolic heat) to maximize the treatment prediction outcome.
    Methodology: A systematic literature review of experimental trials investigating thermophysical and mechanical properties of biological media, as well as blood perfusion and metabolic heat, as a function of temperature in hyperthermic and ablative thermal range, was conducted up to June 2021.
    Results: A total of 61 articles was selected, thus enabling a comprehensive overview of the temperature dependence of thermophysical properties (i.e. thermal conductivity, specific heat, volumetric heat capacity, density, thermal diffusivity), and mechanical properties (shear, elastic, storage, loss and complex moduli, loss factor, stiffness) along with the principal measurement techniques. The reviewed studies considered different tissues, e.g., liver, fat, cartilage, brain, myocardium, muscle, bone, skin, pancreas tissues, and also some tumorous tissues.
    Conclusions: The thermophysical properties of soft tissues appear rather constant until 90 °C, with slight differences ascribable to tissues characteristics and measurement methods. Conversely, the information on mechanical properties is heterogeneous because most of the articles investigated different types of properties in different biological tissues. Furthermore, most of the experiments were conducted
    MeSH term(s) Computer Simulation ; Hot Temperature ; Hyperthermia, Induced/methods ; Models, Biological ; Temperature ; Thermal Conductivity
    Language English
    Publishing date 2022-02-06
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Systematic Review
    ZDB-ID 632526-9
    ISSN 1464-5157 ; 0265-6736
    ISSN (online) 1464-5157
    ISSN 0265-6736
    DOI 10.1080/02656736.2022.2028908
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Interim

    Garibaldi, C / Ferrari, M / Grana, C M / Jereczek-Fossa, B A / Cremonesi, M

    Clinical oncology (Royal College of Radiologists (Great Britain))

    2019  Volume 31, Issue 4, Page(s) 267–268

    Language English
    Publishing date 2019-02-02
    Publishing country England
    Document type Letter
    ZDB-ID 1036844-9
    ISSN 1433-2981 ; 0936-6555
    ISSN (online) 1433-2981
    ISSN 0936-6555
    DOI 10.1016/j.clon.2019.01.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.

    Weber, M / Lam, M / Chiesa, C / Konijnenberg, M / Cremonesi, M / Flamen, P / Gnesin, S / Bodei, L / Kracmerova, T / Luster, M / Garin, E / Herrmann, K

    European journal of nuclear medicine and molecular imaging

    2022  Volume 49, Issue 5, Page(s) 1682–1699

    Abstract: Primary liver tumours (i.e. hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only 10-20% of patients are amenable to curative treatment, such as resection or transplant. ... ...

    Abstract Primary liver tumours (i.e. hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only 10-20% of patients are amenable to curative treatment, such as resection or transplant. Liver metastases are most frequently caused by colorectal cancer, which accounts for the second most cancer-related deaths in Europe. In both primary and secondary tumours, radioembolization has been shown to be a safe and effective treatment option. The vast potential of personalized dosimetry has also been shown, resulting in markedly increased response rates and overall survival. In a rapidly evolving therapeutic landscape, the role of radioembolization will be subject to changes. Therefore, the decision for radioembolization should be taken by a multidisciplinary tumour board in accordance with the current clinical guidelines. The purpose of this procedure guideline is to assist the nuclear medicine physician in treating and managing patients undergoing radioembolization treatment. PREAMBLE: The European Association of Nuclear Medicine (EANM) is a professional non-profit medical association that facilitates communication worldwide among individuals pursuing clinical and research excellence in nuclear medicine. The EANM was founded in 1985. These guidelines are intended to assist practitioners in providing appropriate nuclear medicine care for patients. They are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care. The ultimate judgment regarding the propriety of any specific procedure or course of action must be made by medical professionals taking into account the unique circumstances of each case. Thus, there is no implication that an approach differing from the guidelines, standing alone, is below the standard of care. To the contrary, a conscientious practitioner may responsibly adopt a course of action different from that set out in the guidelines when, in the reasonable judgment of the practitioner, such course of action is indicated by the condition of the patient, limitations of available resources or advances in knowledge or technology subsequent to publication of the guidelines. The practice of medicine involves not only the science but also the art of dealing with the prevention, diagnosis, alleviation and treatment of disease. The variety and complexity of human conditions make it impossible to always reach the most appropriate diagnosis or to predict with certainty a particular response to treatment. Therefore, it should be recognised that adherence to these guidelines will not ensure an accurate diagnosis or a successful outcome. All that should be expected is that the practitioner will follow a reasonable course of action based on current knowledge, available resources and the needs of the patient to deliver effective and safe medical care. The sole purpose of these guidelines is to assist practitioners in achieving this objective.
    MeSH term(s) Bile Duct Neoplasms/drug therapy ; Bile Ducts, Intrahepatic/pathology ; Carcinoma, Hepatocellular/drug therapy ; Carcinoma, Hepatocellular/radiotherapy ; Embolization, Therapeutic ; Humans ; Liver Neoplasms/diagnostic imaging ; Liver Neoplasms/radiotherapy ; Microspheres ; Yttrium Radioisotopes/therapeutic use
    Chemical Substances Yttrium Radioisotopes
    Language English
    Publishing date 2022-02-11
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 8236-3
    ISSN 1619-7089 ; 0340-6997 ; 1619-7070
    ISSN (online) 1619-7089
    ISSN 0340-6997 ; 1619-7070
    DOI 10.1007/s00259-021-05600-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials.

    Stokke, Caroline / Gnesin, Silvano / Tran-Gia, Johannes / Cicone, Francesco / Holm, Søren / Cremonesi, Marta / Blakkisrud, Johan / Wendler, Thomas / Gillings, Nic / Herrmann, Ken / Mottaghy, Felix M / Gear, Jonathan

    European journal of nuclear medicine and molecular imaging

    2024  Volume 51, Issue 5, Page(s) 1268–1286

    Abstract: The numbers of diagnostic and therapeutic nuclear medicine agents under investigation are rapidly increasing. Both novel emitters and novel carrier molecules require careful selection of measurement procedures. This document provides guidance relevant to ...

    Abstract The numbers of diagnostic and therapeutic nuclear medicine agents under investigation are rapidly increasing. Both novel emitters and novel carrier molecules require careful selection of measurement procedures. This document provides guidance relevant to dosimetry for first-in human and early phase clinical trials of such novel agents. The guideline includes a short introduction to different emitters and carrier molecules, followed by recommendations on the methods for activity measurement, pharmacokinetic analyses, as well as absorbed dose calculations and uncertainty analyses. The optimal use of preclinical information and studies involving diagnostic analogues is discussed. Good practice reporting is emphasised, and relevant dosimetry parameters and method descriptions to be included are listed. Three examples of first-in-human dosimetry studies, both for diagnostic tracers and radionuclide therapies, are given.
    MeSH term(s) Humans ; Radiopharmaceuticals/therapeutic use ; Radiometry/methods ; Radionuclide Imaging ; Nuclear Medicine/methods
    Chemical Substances Radiopharmaceuticals
    Language English
    Publishing date 2024-02-17
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 8236-3
    ISSN 1619-7089 ; 0340-6997 ; 1619-7070
    ISSN (online) 1619-7089
    ISSN 0340-6997 ; 1619-7070
    DOI 10.1007/s00259-024-06640-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Biomarkers and Lung Cancer Early Detection: State of the Art.

    Dama, Elisa / Colangelo, Tommaso / Fina, Emanuela / Cremonesi, Marco / Kallikourdis, Marinos / Veronesi, Giulia / Bianchi, Fabrizio

    Cancers

    2021  Volume 13, Issue 15

    Abstract: Lung cancer burden is increasing, with 2 million deaths/year worldwide. Current limitations in early detection impede lung cancer diagnosis when the disease is still localized and thus more curable by surgery or multimodality treatment. Liquid biopsy is ... ...

    Abstract Lung cancer burden is increasing, with 2 million deaths/year worldwide. Current limitations in early detection impede lung cancer diagnosis when the disease is still localized and thus more curable by surgery or multimodality treatment. Liquid biopsy is emerging as an important tool for lung cancer early detection and for monitoring therapy response. Here, we reviewed recent advances in liquid biopsy for early diagnosis of lung cancer. We summarized DNA- or RNA-based biomarkers, proteins, autoantibodies circulating in the blood, as well as circulating tumor cells (CTCs), and compared the most promising studies in terms of biomarkers prediction performance. While we observed an overall good performance for the proposed biomarkers, we noticed some critical aspects which may complicate the successful translation of these biomarkers into the clinical setting. We, therefore, proposed a roadmap for successful development of lung cancer biomarkers during the discovery, prioritization, and clinical validation phase. The integration of innovative minimally invasive biomarkers in screening programs is highly demanded to augment lung cancer early detection.
    Language English
    Publishing date 2021-08-03
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers13153919
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: 2020-21 Influenza vaccination campaign strategy as a model for the third COVID-19 vaccine dose?

    Lecce, Maurizio / Perrone, Pier Mario / Bonalumi, Federica / Castaldi, Silvana / Cremonesi, Monica

    Acta bio-medica : Atenei Parmensis

    2021  Volume 92, Issue S6, Page(s) e2021447

    Abstract: Background and aim: Seasonal influenza exerts a deep and multi-level impact on population and public health systems. Among at risk groups, healthcare workers (HCWs) represent a crucial one due to the threat of absenteeism and consequent disruption of ... ...

    Abstract Background and aim: Seasonal influenza exerts a deep and multi-level impact on population and public health systems. Among at risk groups, healthcare workers (HCWs) represent a crucial one due to the threat of absenteeism and consequent disruption of healthcare services (and economic losses). Also in this group vaccine hesitancy is a well known issue, therefore innovative and 360-degree strategies are urgently needed to overcome the problem.
    Methods: in the 2020-21 influenza vaccination campaign in a research and teaching hospital in Milan, Italy, the working group implemented three different strategies: the offer of vaccination through both an ad hoc ambulatory and several itinerant (on site) vaccinating teams, a promotional and educational communication campaign, a gaming strategy Results: vaccinated employees nearly doubled (2103 vs 1153 in 2019-20 flu vaccination campaign), reaching a comprehensive vaccination coverage rate (VCR) of 43,1%. A highly significant increase in the 40-59 age group was registered. While physicians and nursing staff confirmed to be the most represented categories among vaccinated subjects, administrative and auxiliary staffs performed the greatest increase compared to the previous campaign. The on site vaccination was clearly preferred than the ad hoc one (1693 HCWs, 80,5% vs 410, 19,5%). Vaccinated for the first time registered a significant increase (40,2% vs 36,2% in 2019-20 campaign).
    Conclusions: such meaningful results confirm the effectiveness of the strategies implemented in the present campaign, suggesting their possible application in the debated COVID19-third-dose vaccination campaign.
    MeSH term(s) COVID-19 ; COVID-19 Vaccines ; Health Personnel ; Hospitals, Teaching ; Humans ; Immunization Programs ; Influenza, Human/prevention & control ; SARS-CoV-2 ; Vaccination
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2021-10-19
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2114240-3
    ISSN 2531-6745 ; 0392-4203
    ISSN (online) 2531-6745
    ISSN 0392-4203
    DOI 10.23750/abm.v92iS6.12230
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting.

    Cicone, Francesco / Sarnelli, Anna / Guidi, Claretta / Belli, Maria Luisa / Ferrari, Mahila Esmeralda / Wahl, Richard / Cremonesi, Marta / Paganelli, Giovanni

    Seminars in nuclear medicine

    2022  Volume 52, Issue 2, Page(s) 191–214

    Abstract: Radioimmunotherapy (RIT) is a safe and active treatment available for non-Hodgkin lymphomas (NHLs). In particular, two monoclonal antibodies raised against CD20, that is Zevalin ( ...

    Abstract Radioimmunotherapy (RIT) is a safe and active treatment available for non-Hodgkin lymphomas (NHLs). In particular, two monoclonal antibodies raised against CD20, that is Zevalin (
    MeSH term(s) Antigens, CD20/therapeutic use ; Humans ; Lymphoma, Non-Hodgkin/drug therapy ; Lymphoma, Non-Hodgkin/radiotherapy ; Neoplasm Recurrence, Local/drug therapy ; Radioimmunotherapy/methods ; Tissue Distribution ; Yttrium Radioisotopes/therapeutic use
    Chemical Substances Antigens, CD20 ; Yttrium Radioisotopes
    Language English
    Publishing date 2022-01-05
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 120248-0
    ISSN 1558-4623 ; 0001-2998
    ISSN (online) 1558-4623
    ISSN 0001-2998
    DOI 10.1053/j.semnuclmed.2021.11.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?

    Eberlein, Uta / Cremonesi, Marta / Lassmann, Michael

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    2017  Volume 58, Issue Suppl 2, Page(s) 97S–103S

    Abstract: In 2005, the ... ...

    Abstract In 2005, the term
    MeSH term(s) Diagnosis ; Humans ; Neoplasms/diagnosis ; Neoplasms/radiotherapy ; Nuclear Medicine ; Precision Medicine/methods ; Radiometry/methods ; Radiotherapy
    Language English
    Publishing date 2017-09-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80272-4
    ISSN 1535-5667 ; 0097-9058 ; 0161-5505 ; 0022-3123
    ISSN (online) 1535-5667
    ISSN 0097-9058 ; 0161-5505 ; 0022-3123
    DOI 10.2967/jnumed.116.186841
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Implementation of dosimetry for molecular radiotherapy; results from a European survey.

    Peters, Steffie / Tran-Gia, Johannes / Agius, Sam / Ivashchenko, Oleksandra V / Badel, Jean Noël / Cremonesi, Marta / Kurth, Jens / Gabiña, Pablo Minguez / Richetta, Elisa / Gleisner, Katarina Sjögreen / Tipping, Jill / Bardiès, Manuel / Stokke, Caroline

    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

    2023  Volume 117, Page(s) 103196

    Abstract: Purpose: The use of molecular radiotherapy (MRT) has been rapidly evolving over the last years. The aim of this study was to assess the current implementation of dosimetry for MRTs in Europe.: Methods: A web-based questionnaire was open for treating ... ...

    Abstract Purpose: The use of molecular radiotherapy (MRT) has been rapidly evolving over the last years. The aim of this study was to assess the current implementation of dosimetry for MRTs in Europe.
    Methods: A web-based questionnaire was open for treating centres between April and June 2022, and focused on 2020-2022. Questions addressed the application of 16 different MRTs, the availability and involvement of medical physicists, software used, quality assurance, as well as the target regions for dosimetry, whether treatment planning and/or verification were performed, and the dosimetric methods used.
    Results: A total of 173 responses suitable for analysis was received from centres performing MRT, geographically distributed over 27 European countries. Of these, 146 centres (84 %) indicated to perform some form of dosimetry, and 97 % of these centres had a medical physicist available and almost always involved in dosimetry. The most common MRTs were
    Conclusions: Over the last years, implementation of dosimetry, both for pre-therapeutic treatment planning and post-therapy absorbed dose verification, increased for several treatments, especially for microsphere treatments. For other treatments that have moved from research to clinical routine, the use of dosimetry decreased in recent years. However, there are still large differences both across and within countries.
    MeSH term(s) Radiotherapy Dosage ; Radiometry/methods ; Radiotherapy Planning, Computer-Assisted/methods ; Europe
    Language English
    Publishing date 2023-12-16
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 1122650-x
    ISSN 1724-191X ; 1120-1797
    ISSN (online) 1724-191X
    ISSN 1120-1797
    DOI 10.1016/j.ejmp.2023.103196
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top